我院肿瘤患者人血白蛋白临床应用分析Δ

摘要

OBJECTIVE:To provide references for rational clinical application of human serum albumin. METHODS:By adopting retrospective analysis,medical records of 256 tumor inpatients administered with human serum albumin in the affiliated cancer hospital of zhengzhou university during Jan. and Jun. 2014 were randomly selected to statistically analyze the drug consump-tion amount per capita,average course of treatment and the concentration of serum albumin in the patient before administration. RE-SULTS:In our hospital,human serum albumin was used in 15 clinical departments,mainly in non-surgical departments. The pa-tients received drugs at a single dose ranging from 10 to 20 g. Postoperative patients with hypoalbuminemia topped the list in terms of daily consumption amount of human serum albumin(15.82 g/d)and patients with hypoalbuminemia accompanied by ascites and pleural effusion experienced the longest average course of treatment(6.93 d). Human serum albumin was mainly used for hypopro-teinemia. CONCLUSIONS:The use of human serum albumin in our hospital conformed to the dispensatory and the regulations on the medical insurance organizations of Henan Province. However,it is not in compliance with the regulations on the medical insur-ance organizations of Beijing and the guidelines of the hospital associations of American universities. Therefore,the indication of human serum albumin needs to be further defined,and priority should be given to nutrition supply for the inpatient with hypoalbu-minemia caused by malnutrition.%目的：为临床合理使用人血白蛋白提供参考。方法：采用回顾性分析方法，抽取郑州大学附属肿瘤医院2014年1－6月应用人血白蛋白的256例住院肿瘤患者病历，对人均用药量、平均用药疗程、用药前患者血清白蛋白浓度等进行统计、分析。结果：我院人血白蛋白的使用范围涉及全院15个临床科室，主要以非手术科室为主；患者单次用量为10～20 g不等；术后低蛋白血症患者人均日用量最高，为15.82 g/d；低蛋白血症伴胸、腹水患者平均用药疗程最长，为6.93 d；用药原因均为低蛋白血症。结论：我院人血白蛋白的使用符合药品说明书及河南省医保机构的规定，但尚不符合北京市医保机构和美国大学医院联合会相关指南/指导原则的规定，因此关于人血白蛋白的使用指征需进一步明确；对于营养不良型低蛋白血症患者应重视营养的供给。